Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT04992000 Completed - Hypertension Clinical Trials

Self-Care of Hypertension Among Older Adults During COVID-19

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

This study aimed to examine the effects of a public health nursing intervention plus m-Health applications for hypertension management on enhancing the Self-care, systolic and diastolic blood pressure, and quality of life in older adults during the lockdown period in Jordan. Study Hypothesis: There are no differences between the three groups in: H01 HTN self-care (SC-HI) score. H02 Health-related quality of life (SF-36) score. H03 The management of systolic and diastolic BP levels.

NCT ID: NCT04991961 Recruiting - Hypertension Clinical Trials

Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Screening for Primary Aldosteronism

HASA
Start date: September 15, 2020
Phase:
Study type: Observational

To evaluate the effect of anti-hypertensive medication on efficiency of primary aldosteronism screening test, and to determine the appropriate diagnostic cutoff value for Chinese hypertension patients during antihypertensive drugs therapy.

NCT ID: NCT04991454 Recruiting - Clinical trials for Pulmonary Hypertension

Xenon MRI Pulm Hypertension

Jupiter PH
Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

The overall objective outlined in this study is to determine how pulmonary vascular remodeling in PAH at a cellular and pathological level is associated with changes in gas exchange physiology and hemodynamics (monitored with 129Xe MRI/MRS) and how these signals change with disease progression or treatment.

NCT ID: NCT04991207 Completed - Clinical trials for Pulmonary Arterial Hypertension

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Start date: February 6, 2018
Phase: Phase 1
Study type: Interventional

the purpose of this study is: - To assess the effect of BIA 5 1058 400 mg on the PK of bosentan. - To assess the effect of bosentan on the PK of BIA 5 1058

NCT ID: NCT04991194 Terminated - Clinical trials for Pulmonary Arterial Hypertension

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Start date: October 12, 2015
Phase: Phase 1
Study type: Interventional

the purpose of this study is to determine the effect of age on the Pharmacokinetics (PK) profile of BIA 5-1058 at steady state after multiple oral doses

NCT ID: NCT04991181 Completed - Clinical trials for Pulmonary Arterial Hypertension

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058

ADME
Start date: March 31, 2017
Phase: Phase 1
Study type: Interventional

the purpose of this study is: - to determine the rate and routes of excretion of BIA 5-1058 and the mass balance in urine, feces and exhaled air, after a single oral dose of 400 mg 14C labeled BIA 5 1058 containing 3.7 Megabecquerel (MBq) of radiocarbon; - to determine the pharmacokinetics (PK) of total radioactivity (TRA) in plasma and whole blood and to assess the blood-to-plasma ratio; - to determine the PK of BIA 5-1058 and its metabolites in plasma.

NCT ID: NCT04991155 Completed - Clinical trials for Pulmonary Arterial Hypertension

Effect of Food on BIA 5-1058

Start date: July 20, 2015
Phase: Phase 1
Study type: Interventional

The aim of this study is to investigate the effect of food on the pharmacokinetic (PK) profile of BIA 5-1058 after a single dose in healthy subjects.

NCT ID: NCT04991077 Recruiting - Clinical trials for Malignant Hypertension

Interrupters of VAscular daMAge in Malignant Hypertension

IVAMA
Start date: February 7, 2022
Phase:
Study type: Observational

The pathophysiology of malignant hypertension is poorly understood. The objective of this translational research project is to evaluate the relationship between activation of vasoactive systems (renin-angiotensin and endothelin systems), angiogenic signal deficiency (VEGF and sFlt-1) and the occurrence of malignant hypertension episodes in humans.

NCT ID: NCT04989634 Recruiting - Clinical trials for Gestational Diabetes Mellitus

Effects of Dietary and Weight Management on Pregnancy Outcomes in Mobile Medical Platform

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

With the opening up of the two-child policy , the composition of pregnant women in China has changed significantly . The proportion of high-risk pregnant women in the elderly has increased significantly , and the risk of adverse pregnancy outcomes has also increased . Among them , gestational diabetes mellitus ( GDM ) is the most common complication during pregnancy . The incidence of GDM in China is as high as 18 % due to the economic growth , lifestyle changes and dietary habits . GDM not only threatens perinatal maternal and child health , but also increases the risk of offspring insulin resistance , obesity and metabolic diseases in adulthood . But it is still lack of experience on intervening and managing them effectively. Therefore , on the basis of previous studies , this study intends to explore the effects of intensive diet and exercise intervention by obstetricians and nutritionists on pregnancy weight gain , pregnancy outcome , glucose and lipid metabolism and postpartum weight retention under the mobile medical platform through a large sample cluster intervention test in the real world. In order to supervise and improve the compliance of the intervention subjects and realize the ultimate change of their behaviors, this study intends to use the APP software, the mobile medical technology, to monitor and evaluate diet , exercise and weight. Through the above research , it aims to improve the current management schemes of diet and weight during pregnancy , not only helps to optimize and improve the quality of perinatal health care , but also prevents the adult chronic diseases from the fetal period. This research has important theoretical and practical value .

NCT ID: NCT04988100 Not yet recruiting - Clinical trials for Living Donor Liver Transplantation

Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

In this study, the investigators aim to prove that performing splenic artery ligation in living donor liver transplantation for patients with portal hypertension is beneficial for early graft function postoperatively. The investigators will be analyzing trend of LFT's (liver function tests) after surgery, time for normalization of bilirubin, INR (international normalised ratio) and decrease in ascites, morbidity, mortality, ICU (intensive care unit) and total hospital stay.